Apotea AB (publ)FRA:V30 +1.33%19 EBIT per Share is €0.27 as of Mar. 2026. GuruFocus rates FRA:V30 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 529 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 96.22% on this metric.
Apotea AB (publ)'s EBIT per Share for the
three
months ended in Mar. 2026 was €0.09.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.27.
During the past 12 months, the average EBIT per Share Growth Rate of Apotea AB (publ) was 3.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 83.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Apotea AB (publ)'s EBIT per Share or its related term are showing as below:
FRA:V30'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 25.7 Med: 54.65 Max: 83.6
Current: 83.6
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Apotea AB (publ) was 83.60% per year. The lowest was 25.70% per year. And the median was 54.65% per year.
FRA:V30's 3-Year EBIT Growth Rate is ranked better than 96.22% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 12.1
vs FRA:V30: 83.60
Apotea AB (publ) (FRA:V30) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Apotea AB (publ) EBIT per Share Related Terms
Apotea AB (publ) EBIT per Share Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (FRA:V30) has a EBIT per Share of €0.27 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Apotea AB (publ) and its competitors. According to the industry distribution chart, Apotea AB (publ) ranks #20 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 3.8%.
Is Apotea AB (publ)'s EBIT per Share too high?
Apotea AB (publ)'s current EBIT per Share is €0.27. Based on the distribution chart, Apotea AB (publ) ranks #20 out of 529 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Apotea AB (publ) has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #20 out of 529 companies for EBIT per Share. This places Apotea AB (publ) in the top 4% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current EBIT per Share is €0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (FRA:V30) has a current EBIT per Share of €0.27. The current EBIT per Share is €0.27. Apotea AB (publ)'s overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Apotea AB (publ) (FRA:V30), the current EBIT per Share is €0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
19GF Score
Get the complete analysis for FRA:V30
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V30 has been successfully added to your 
